Article
Genome-Informed Targeted Therapy for Osteosarcoma
28 Sept 2018
Abstract excerpt
Abstract Osteosarcoma is a highly aggressive cancer for which treatment has remained essentially unchanged for more than 30 years. Osteosarcoma is characterized by widespread and recurrent somatic copy-number alterations (SCNA) and structural rearrangements. In contrast, few recurrent point mutations in protein-coding genes have been identified, suggesting that genes within SCNAs are key oncogenic drivers in this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
